Editor’s note – Express Pharma

Why drug repurposing needs first good science, then hope

Learning to live with COVID-19

Will the industry sell COVID-19 meds at the min production costs?

China’s recovery from COVID-19 should not tempt us to take the easy way out again

Lessons from COVID-19

2019-nCoV, nitrosamine issues trigger supply chain re-jigs

2019-nCoV must reform India Pharma Inc

2019-nCoV: A wake-up call

Will Budget 2020 be a salve or a sting for India Pharma Inc?

Why API price needs to be part of NPPA’s pricing formula